Foley Secures Rare Inter Partes Review Wins for Patent Owner Supernus Pharmaceuticals
December 10, 2014
Foley secured three significant inter partes review victories on behalf of Supernus Pharmaceuticals, Inc. and Galderma S.A. for a pharmaceutical product, which represents one of the first inter partes reviews to reach a final decision in favor of the patent owner, where the patents were the subject of a parallel Hatch-Waxman patent litigation. The inter partes reviews were filed by a “generic” company that filed an Abbreviated New Drug application to market a generic version of the product Oracea®.
The Foley team, led by Stephen Maebius, included Andrew Baluch, George Quillin, and Sunit Talapatra.
People
Related News
May 22, 2025
Press Releases
Foley Continues Expansion in California with Two Corporate Partners in Silicon Valley
Foley & Lardner LLP announced today that it has expanded its Innovative Technology Sector and Transactions Practice Group with the addition of partners Gurpreet Bal and Shaalu Mehra to the firm’s Silicon Valley office. Both attorneys bring substantial experience advising technology companies, investors, and founders on complex transactional and corporate matters.
May 12, 2025
Press Releases
Foley Expands East Coast Litigation Bench, Adds Three Partners in New York and Raleigh
Foley & Lardner LLP announced today that it has strengthened its East Coast presence with the addition of three partners to its Litigation Department.
May 8, 2025
Press Releases
Foley Expands Technology and Energy Capabilities with Addition of Two Digital Infrastructure Partners
Foley & Lardner LLP announced today the addition of partners Daniel Farris and Joe McClendon to its Chicago office, further enhancing the firm’s Technology Transactions, Cybersecurity, and Privacy Practice and its Energy & Infrastructure and Innovative Technology Sectors.